Eargo, Inc. (EAR)
After hours:
| Previous close | 0.7519 |
| Open | 0.7568 |
| Bid | 0.7501 x 2200 |
| Ask | 0.7800 x 1100 |
| Day's range | 0.7237 - 0.7800 |
| 52-week range | 0.7237 - 39.0900 |
| Volume | |
| Avg. volume | 1,010,553 |
| Market cap | 29.71M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.6510 |
| Earnings date | 23 Feb 2022 - 28 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.50 |
- GlobeNewswire
Eargo Strengthens Financial Position with up to $125 Million Strategic Investment from Patient Square Capital
Company to Hold Conference Call and Webcast on June 27, 2022 at 8 a.m. Eastern TimeSAN JOSE, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has signed a definitive agreement with Patient Square Capital (“Patient Square”) to raise $100 million through the sale of senior secured convertible notes, with an additional $25 million future investment
- GlobeNewswire
Eargo to Present at the William Blair 42nd Annual Growth Stock Conference
SAN JOSE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the William Blair 42nd Annual Growth Stock Conference. Christian Gormsen, Eargo’s President and Chief Executive Officer, is scheduled to present on Thursday, June 9th at 11:40 a.m. Eastern Time (8:40 a.m. Pacific Time). The live web cast of Eargo’s presentation can be accessed at www.ea
- GlobeNewswire
Nasdaq Confirms Continued Listing of Eargo Stock
SAN JOSE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, announced today that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated May 26, 2022 informing Eargo that the Company’s filing delinquency for the period ended March 31, 2022 has been cured, that the scheduled hearing on June 16, 2022 has been cancelled, that the Nasdaq matter
